متابعة
Rodrigo A Bressan
Rodrigo A Bressan
Professor Adjunto Livre Docente, Universidade Federal de São Paulo
بريد إلكتروني تم التحقق منه على unifesp.br
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
Mapping genomic loci implicates genes and synaptic biology in schizophrenia‏
V Trubetskoy, AF Pardiñas, T Qi, G Panagiotaropoulou, S Awasthi, ...‏
Nature 604 (7906), 502-508, 2022‏
11002022
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology‏
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...‏
American Journal of Psychiatry 174 (3), 216-229, 2017‏
9032017
Cannabis use before age 15 and subsequent executive functioning‏
MA Fontes, KI Bolla, PJ Cunha, PP Almeida, F Jungerman, RR Laranjeira, ...‏
The British Journal of Psychiatry 198 (6), 442-447, 2011‏
3612011
First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients‏
LS Pilowsky, RA Bressan, JM Stone, K Erlandsson, RS Mulligan, ...‏
Molecular psychiatry 11 (2), 118-119, 2006‏
3412006
The role of dopamine in reward and pleasure behaviour–review of data from preclinical research‏
RA Bressan, JA Crippa‏
Acta Psychiatrica Scandinavica 111, 14-21, 2005‏
3412005
A general psychopathology factor (P factor) in children: Structural model analysis and external validation through familial risk and child global executive function.‏
MM Martel, PM Pan, MS Hoffmann, A Gadelha, MC do Rosário, JJ Mari, ...‏
Journal of abnormal psychology 126 (1), 137, 2017‏
2782017
Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations‏
European Network of National Networks studying Gene-Environment Interactions ...‏
Schizophrenia bulletin 40 (4), 729-736, 2014‏
2732014
High risk cohort study for psychiatric disorders in childhood: rationale, design, methods and preliminary results‏
GA Salum, A Gadelha, PM Pan, TS Moriyama, AS Graeff‐Martins, ...‏
International journal of methods in psychiatric research 24 (1), 58-73, 2015‏
1862015
Using deep belief network modelling to characterize differences in brain morphometry in schizophrenia‏
WHL Pinaya, A Gadelha, OM Doyle, C Noto, A Zugman, Q Cordeiro, ...‏
Scientific reports 6 (1), 38897, 2016‏
1782016
The impact of epidemic violence on the prevalence of psychiatric disorders in Sao Paulo and Rio de Janeiro, Brazil‏
WS Ribeiro, JJ Mari, MI Quintana, ME Dewey, S Evans-Lacko, LMP Vilete, ...‏
PloS one 8 (5), e63545, 2013‏
1702013
Impact of childhood stress on psychopathology‏
E Brietzke, M Kauer-Sant'anna, A Jackowski, R Grassi-Oliveira, J Bucker, ...‏
Brazilian Journal of Psychiatry 34, 480-488, 2012‏
1542012
Gray matter volumes in obsessive-compulsive disorder before and after fluoxetine or cognitive-behavior therapy: a randomized clinical trial‏
MQ Hoexter, FL de Souza Duran, CC D'alcante, DD Dougherty, ...‏
Neuropsychopharmacology 37 (3), 734-745, 2012‏
1472012
Structural validity and reliability of the Positive and Negative Affect Schedule (PANAS): evidence from a large Brazilian community sample‏
HW Carvalho, SB Andreoli, DR Lara, CJ Patrick, MI Quintana, RA Bressan, ...‏
Brazilian Journal of Psychiatry 35, 169-172, 2013‏
1462013
Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I] epidepride SPET study of amisulpride-treated patients‏
RA Bressan, K Erlandsson, HM Jones, R Mulligan, RJ Flanagan, PJ Ell, ...‏
American Journal of Psychiatry 160 (8), 1413-1420, 2003‏
1452003
Ventral striatum functional connectivity as a predictor of adolescent depressive disorder in a longitudinal community-based sample‏
PM Pan, JR Sato, GA Salum, LA Rohde, A Gadelha, A Zugman, J Mari, ...‏
American Journal of Psychiatry 174 (11), 1112-1119, 2017‏
1382017
Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis‏
C Noto, VK Ota, ES Gouvea, LB Rizzo, LMN Spindola, PHS Honda, ...‏
International Journal of Neuropsychopharmacology 18 (4), pyu042, 2015‏
1332015
Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study‏
JM Stone, K Erlandsson, E Arstad, L Squassante, V Teneggi, RA Bressan, ...‏
Psychopharmacology 197, 401-408, 2008‏
1322008
Towards a multifactorial approach for prediction of bipolar disorder in at risk populations‏
E Brietzke, RB Mansur, JK Soczynska, F Kapczinski, RA Bressan, ...‏
Journal of affective disorders 140 (1), 82-91, 2012‏
1302012
Typical antipsychotic drugs—D2 receptor occupancy and depressive symptoms in schizophrenia‏
RA Bressan, DC Costa, HM Jones, PJ Ell, LS Pilowsky‏
Schizophrenia Research 56 (1-2), 31-36, 2002‏
1172002
Bitopertin in negative symptoms of schizophrenia—results from the phase III FlashLyte and DayLyte studies‏
D Bugarski-Kirola, T Blaettler, C Arango, WW Fleischhacker, G Garibaldi, ...‏
Biological psychiatry 82 (1), 8-16, 2017‏
1152017
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20